Effect of Compression Garments on Exercise Performance Following Acute High Intensity Exercise
NCT ID: NCT02076334
Last Updated: 2017-07-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2014-02-28
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sex Differences in Muscle Damage Following Resistance Exercise at Low or High Intensity
NCT05111054
Arm Compression on Muscle Oxygen Saturation
NCT05037071
The Effect of Compression Stockings During Training on Running Performance
NCT04353219
The Effect of Post-Training Cold Compression in Professional Volleyball Players
NCT06701435
The Effect of Soft Tissue Mobilization and Kinesio Taping Applied to Athletics Athletes on Sports Performance
NCT06407466
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Procedures (methods): During pre-screening, each participant will complete an informed consent document, a health history questionnaire, and have their stature and body mass assessed. A familiarization session will then be conducted on a separate day where all participants will practice the strength assessment, eccentric isokinetic protocol, and ultrasound assessments. Participants will be assigned to 1 of the 4 treatment groups based on their initial maximal isometric strength values using a matched-participants design. The first experimental session will then begin 2-10 days later, where the participants will perform the repeated eccentric exercise protocol (10 sets of 15 eccentric contractions 210 deg/sec with 3 min of rest between sets) with the non-dominant leg following a 60 min rest period where they will wear the apparel and perform a 5 min warm-up on a cycle ergometer. Follow-up blood draws and strength and ultrasound assessments will be obtained at 24 and 48 hours post-exercise. Each participant will also complete a visual analog scale at baseline, 24, 48, and 72 hours post-exercise to examine perceived muscle soreness.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Compression + normal garment
Far Infrared Fabric during exercise + Spandex at night
Far Infrared Fabric
Spandex
Normal Garment + Test garment at night
Spandex during exercise + Far Infrared Fabric at night
Far Infrared Fabric
Spandex
Normal Garment + normal garment
Spandex during exercise + Spandex at night
Spandex
Test garment + Test garment
Far Infrared Fabric during exercise + Far Infrared Fabric at night
Far Infrared Fabric
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Far Infrared Fabric
Spandex
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant is between the ages of 18-35
* Healthy, Recreationally Active (1-5 hours per week)
* Participant has provided written and dated informed consent to participate in the study
* Participant is apparently healthy and free from disease, as determined by a health history questionnaire
* Participant agrees to abstain from smoking, caffeine (4hrs prior), tobacco (24hrs prior), and alcohol (24 hrs) before testing days
* Participant agrees to abstain from exercise 24 hours prior to each testing visit and after 72 hours of the induced exercise damage
* Participant will refrain from the use of non-steroidal anti-inflammatory drugs (NSAIDs) and protein supplementation 24 hours before the exercise testing protocol, as well as for the 72 hour period following the exercise testing protocol.
Exclusion Criteria
* Participant is in, or has participated in another clinical trial within 6 weeks prior to enrollment
* Participant has a known allergy or sensitivity to test product (determined from health history questionnaire and consent form)
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rhodia, Inc
UNKNOWN
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abbie Smith-Ryan, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Exercise and Sport Science (University of North Carolina)
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-3101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.